The Centers for Medicare & Medicaid Services has approved a new Healthcare Common Procedure Coding System code for the NeuroNode, patent technology by Control Bionics (ASX: CBL). This approval, effective from 1 October 2024, introduces a reimbursement rate of US$4,300 for the NeuroNode, a significant enhancement from the previous reimbursement conditions. Control Bionics is a
Read More
Australian semiconductor company Archer Materials (ASX: AXE) has progressed its latest Biochip design to the next phase of development by dispatching it to the VTT Technical Research Centre of Finland Ltd (VTT) for manufacturing. The Biochip’s newest graphene field-effect transistor (gFET) design, which was announced in July 2024, marks a milestone in enhancing it’s functionality,
Read More
As Australia battles economic uncertainty which has seen a major pullback in household spending, mortgages stress is pushing many families to breaking point with a bumper result for property tech company Domain Holdings (ASX: DHG) which has seen more listings at a time when borrowing power is weakened due to high interest rates. For the
Read More
Cost-of-living pressures and the inflationary pressure on raw materials is having an impact on childcare operator Nido Education (ASX: NDO) which has forewarned that it is unlikely to meet the profit expectations for 2024 that were outlined in their IPO Prospectus when listing on the ASX in October 2023. The childcare centre operator has cited
Read More
The XJO is expected to open higher this morning following a strong jump from the U.S overnight. Their futures are flat. Despite the stella run we have seen over the past couple of the weeks, the U.S managed to rally once again overnight, breaking the 50 day MA and the tentative downtrend line. Our market
Read More
Firebrick Pharma (ASX: FRE) is making waves with its Nasodine Nasal Spray disinfectant, having recently executed an amended licence and distribution agreement to bring the product to the Philippines. The amended agreement with S.V. More Pharma Corporation (SV More) allows for the local manufacture of Nasodine, shifting from its previous importation from Australia. This strategic
Read More
